Residency · Mineola, NY
Sponsored by NYU Grossman Long Island School of Medicine
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
The New England journal of medicine · 2021 · 1,467 citations · Kalgi Mody
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Lancet (London, England) · 2025 · 275 citations · Kalgi Mody
Diagnosis of neonatal sepsis: the past, present and future.
Pediatric research · 2022 · 160 citations · Morcos Hanna
Health Literacy, Digital Health Literacy, and COVID-19 Pandemic Attitudes and Behaviors in U.S. College Students: Implications for Interventions.
International journal of environmental research and public health · 2021 · 132 citations · Uday Patil
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
The Lancet. Oncology · 2023 · 140 citations · Kalgi Mody
Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth.
The Journal of pediatrics · 2021 · 152 citations ·
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2023 · 77 citations · Daniel Ruderfer
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit.
Nature cancer · 2025 · 35 citations · Tal Cohen